Teresa Lambe FMedSci is a Principal Investigator based at the Oxford Vaccine Group in the Department of Paediatrics. Her area of expertise is vaccine development and immune profiling.
Teresa is an experienced immunologist who develops vaccines against emerging and outbreak pathogens. She is experienced at progressing preclinical concepts all the way through to clinical assessment. Her team is working on delineating the immune response against a number of emerging or outbreak pathogens (including Ebolavirus, CCHF and coronaviruses) and using this information to aid in vaccine development against these pathogens.
Teresa and her team started developing a vaccine against SARS-CoV-2 in early 2020, this vaccine has been extensively tested and the ChAdOx1 nCoV-19/AZD1222 has now been licensed in more than 170 countries - becoming a critical tool in the fight against COVID-19.
Tess is also the College Champion for Equality, Diversity and Inclusion.
